Brendan Guercio
@BrendanGuercio
Followers
337
Following
712
Statuses
219
GU Oncologist at @UofR @WilmotCancer | Alumnus @MSKCancerCenter @BrighamMedRes @harvardmed | Views my own.
Joined July 2015
Incredibly grateful to @BladderCancerUS for the opportunity to define the impact of diet & microbiome to help patients w/ #bladdercancer. Thank you to project mentors @IyerGopa @LPeppone, advocate Rick Bangs, and collaboration of so many @tsonipeled @DrRosenbergMSK @PaulBarrMD
Please join BCAN in congratulating the recipients of our 2024 Career Development Award, @anglayteng of @Stanford and @BrendanGuercio of @wilmotcancer. Both Drs. Ang and Guercio presented outstanding proposals that you can learn more about here:
4
3
35
RT @sonpavde: #GU25: Key #bladdercancer presentations (in my opinion)- highlights and summary coming after the conference from @AdventHealt…
0
16
0
The decrease in @NIH funding is a tragedy for patients. Less funding means less scientific research, which means fewer new cures for our patients. Anyone who cares about curing patients with #cancer and other diseases should be dismayed.
These great research institutions in red states are slated to lose about $1B in NIH research dollars
0
3
4
RT @urotoday: 5-Year survival outcomes in cisplatin-ineligible patients from #EV103. @DrRosenbergMSK @MSKCancerCenter joins @CaPsurvivorshi…
0
1
0
RT @tompowles1: Bladder cancer highlights #ASCOGU25 1) outcomes of pCR patients for gem/cis/durvalumab (NIAGARA) 2) neoadjuvant gem/cis/dur…
0
27
0
A fantastic panel! Very much looking forward to this event
🚨In <1 wk, it’s #GU25🚨 Let’s🗣️the current SoC➕how the data will change/reinforce our practice at #AdvInOnc25: - Bladder Ca - Prostate Ca - RCC *Join us LIVE* 📅 Date: Feb 12, 2025 ⏰ Time: 6:00-8:00PM 📝 #OncTwitter #MedTwitter #gusm @OncoAlert
0
1
3
@LPeppone @BladderCancerUS @IyerGopa @tsonipeled @DrRosenbergMSK @PaulBarrMD Thank you for your mentorship & support!
0
0
1
RT @DrChoueiri: 1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tum…
0
204
0
@OncBrothers @BladderCancerUS @IyerGopa @LPeppone @tsonipeled @DrRosenbergMSK @PaulBarrMD Thank you!
0
0
3
@AmandaNizamMD @BladderCancerUS @IyerGopa @LPeppone @tsonipeled @DrRosenbergMSK @PaulBarrMD @LauraBukavinaMD Would love to, thank you!
0
0
2
RT @BladderCancerUS: BCAN's 2nd 2024 Career Development Award recipient is @BrendanGuercio. Dr. Guercio will examine examine if a high-fib…
0
2
0
@FaltasLab @BladderCancerUS @anglayteng Thank you! Thrilled and humbled to receive this award to conduct further research to help our patients!
0
0
3
RT @BladderCancerUS: 🚨 PLEASE SHARE! Early-career bladder cancer researchers: Apply now for BCAN's 2025 Young Investigator Awards! $75K in…
0
12
0
RT @DrRosenbergMSK: The MSK GU Service recently celebrated the illustrious career of Dr. Dean Bajorin. We will miss his wisdom, insight, hu…
0
15
0
RT @darbysaxbe: I need people to understand how difficult it is to get an NIH grant. You spend months writing a proposal, following strict…
0
4K
0
RT @Dr_Aggen: At #AUC3 this A.M. discussing what’s next for treatment of NMIBC and treatment of variant histology UC. @IyerGopa @JoshMeeks…
0
2
0
RT @DrRosenbergMSK: This important study by Dr. Chen and his laboratory showed that Kmt2c/d functional loss leads to a molecular 'field eff…
0
15
0
The MODERN trial has the potential to reduce over treatment of low risk patients and simultaneously improve survival of high risk patients with novel immunotherapy. Can’t wait to see the results make a brighter future for patients affected by #bladdercancer!
Please support Alliance A032103 to define the role of ctDNA-based adjuvant therapy decision making in #BladderCancer. @ALLIANCE_org @BladderCancerUS @Uromigos @urotoday @alantanmd @TischCancer @CDNCancerTrials @SWOG @eaonc @WorldBladderCan
0
1
5
RT @urotoday: 5-Year survival outcomes in cisplatin-ineligible patients from #EV103. @DrRosenbergMSK @MSKCancerCenter joins @CaPsurvivorshi…
0
14
0